Bepotastine D4
| Product Name | Bepotastine D4 |
|---|---|
| Alternate Names | Bepotastine Stable Isotopes, Stable Isotopes of Bepotastine |
| CAT No. | CS-O-20037 |
| CAS No. | 125602-71-3(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 392.91 g/mol |
| Mol. For. | C₂₁H21D₄ClN₂O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bepotastine |
| Purity | Not less than 90 % |
| Smileys | ClC1=CC=C(C=C1)[C@@H](C2=CC=CC=N2)OC3CCN(CC([2H])([2H])C([2H])([2H])C(O)=O)CC3 |
| Canonical Smiles | C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O |
| InchIKey | YWGDOWXRIALTES-NRFANRHFSA-N |
| Inchl | InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1 |
| IUPAC | 4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bepotastine D4 is a deuterated version of the antihistamine drug Bepotastine. It is used as a therapeutic agent for the treatment of allergic rhinitis and urticaria. Bepotastine D4 is a selective histamine H1 receptor antagonist. It works by blocking the histamine receptors that cause allergy symptoms, such as itching, sneezing, and runny nose. The deuterated version of bepotastine allows for better pharmacokinetic properties, including better absorption, distribution, and metabolism.
The chemical formula of Bepotastine D4 is C21H24D4N2O3, with a molecular weight of 368.5 g/mol. It is a white to off-white crystalline powder that is soluble in water and ethanol. Bepotastine D4 is commonly administered orally in tablet form, with a recommended dose of 10mg once daily, preferably at bedtime.
Clinical studies have shown that Bepotastine D4 is well-tolerated and has a good safety profile. Adverse effects are generally mild and include somnolence, headache, and dry mouth. It is important to note that Bepotastine D4 may interact with other drugs, including CNS depressants, and caution should be taken when administering it in combination with other medications.
In conclusion, Bepotastine D4 is a useful drug for the treatment of allergic rhinitis and urticaria. It works by blocking histamine receptors and has a good safety profile.
Get an Instant Quote
Related Compounds
Bepotastine-d4 Besylate |